These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38593213)

  • 41. LncRNA PTCSC3 inhibits triple-negative breast cancer cell proliferation by downregulating lncRNA H19.
    Wang N; Hou M; Zhan Y; Sheng X
    J Cell Biochem; 2019 Sep; 120(9):15083-15088. PubMed ID: 31026090
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long non-coding RNA linc00921 suppresses tumorigenesis and epithelial-to-mesenchymal transition of triple-negative breast cancer via targeting miR-9-5p/LZTS2 axis.
    Zhang J; Zhang L; Wang J; Zhao J; Zhao X; Zhang C; Han P; Geng C
    Hum Cell; 2022 May; 35(3):909-923. PubMed ID: 35179718
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long non-coding RNA MIDEAS-AS1 inhibits growth and metastasis of triple-negative breast cancer via transcriptionally activating NCALD.
    Luo D; Liang Y; Wang Y; Ye F; Jin Y; Li Y; Han D; Wang Z; Chen B; Zhao W; Wang L; Chen X; Jiang L; Yang Q
    Breast Cancer Res; 2023 Sep; 25(1):109. PubMed ID: 37770991
    [TBL] [Abstract][Full Text] [Related]  

  • 44. RB1 deficiency in triple-negative breast cancer induces mitochondrial protein translation.
    Jones RA; Robinson TJ; Liu JC; Shrestha M; Voisin V; Ju Y; Chung PE; Pellecchia G; Fell VL; Bae S; Muthuswamy L; Datti A; Egan SE; Jiang Z; Leone G; Bader GD; Schimmer A; Zacksenhaus E
    J Clin Invest; 2016 Oct; 126(10):3739-3757. PubMed ID: 27571409
    [TBL] [Abstract][Full Text] [Related]  

  • 45. LncRNA T376626 is a promising serum biomarker and promotes proliferation, migration, and invasion via binding to LAMC2 in triple-negative breast cancer.
    He Y; Xiao B; Lei T; Xuan J; Zhu Y; Kuang Z; Liu J; He J; Li L; Sun Z
    Gene; 2023 Apr; 860():147227. PubMed ID: 36709879
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long non‑coding RNA SChLAP1 regulates the proliferation of triple negative breast cancer cells via the miR‑524‑5p/HMGA2 axis.
    Bai X; Zhang S; Qiao J; Xing X; Li W; Zhang H; Xie J
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33846810
    [TBL] [Abstract][Full Text] [Related]  

  • 47. LncRNA DLX6-AS1 Contributes to Epithelial-Mesenchymal Transition and Cisplatin Resistance in Triple-negative Breast Cancer via Modulating Mir-199b-5p/Paxillin Axis.
    Du C; Wang Y; Zhang Y; Zhang J; Zhang L; Li J
    Cell Transplant; 2020; 29():963689720929983. PubMed ID: 32686982
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proliferation-associated long noncoding RNA, TMPO-AS1, is a potential therapeutic target for triple-negative breast cancer.
    Mitobe Y; Ikeda K; Sato W; Kodama Y; Naito M; Gotoh N; Miyata K; Kataoka K; Sasaki H; Horie-Inoue K; Inoue S
    Cancer Sci; 2020 Jul; 111(7):2440-2450. PubMed ID: 32437068
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long non-coding RNA MALAT1 promotes proliferation and invasion via targeting miR-129-5p in triple-negative breast cancer.
    Zuo Y; Li Y; Zhou Z; Ma M; Fu K
    Biomed Pharmacother; 2017 Nov; 95():922-928. PubMed ID: 28915533
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of insulin-like growth factor-binding protein-3 signaling through sphingosine kinase-1 sensitizes triple-negative breast cancer cells to EGF receptor blockade.
    Martin JL; de Silva HC; Lin MZ; Scott CD; Baxter RC
    Mol Cancer Ther; 2014 Feb; 13(2):316-28. PubMed ID: 24337110
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Upregulation of FGF9 and NOVA1 in cancer-associated fibroblasts promotes cell proliferation, invasion and migration of triple negative breast cancer.
    Zhang B; Liu Y; Yu J; Lin X
    Drug Dev Res; 2024 May; 85(3):e22185. PubMed ID: 38657094
    [TBL] [Abstract][Full Text] [Related]  

  • 52. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
    Guo GC; Wang JX; Han ML; Zhang LP; Li L
    Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
    Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
    BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Histone Deacetylase Inhibitor Enhances the Efficacy of MEK Inhibitor through NOXA-Mediated MCL1 Degradation in Triple-Negative and Inflammatory Breast Cancer.
    Torres-Adorno AM; Lee J; Kogawa T; Ordentlich P; Tripathy D; Lim B; Ueno NT
    Clin Cancer Res; 2017 Aug; 23(16):4780-4792. PubMed ID: 28465444
    [No Abstract]   [Full Text] [Related]  

  • 55. LncRNA ZFAS1 inhibits triple-negative breast cancer by targeting STAT3.
    Sharma U; Barwal TS; Khandelwal A; Malhotra A; Rana MK; Singh Rana AP; Imyanitov EN; Vasquez KM; Jain A
    Biochimie; 2021 Mar; 182():99-107. PubMed ID: 33429003
    [TBL] [Abstract][Full Text] [Related]  

  • 56. TCOF1 upregulation in triple-negative breast cancer promotes stemness and tumour growth and correlates with poor prognosis.
    Hu J; Lai Y; Huang H; Ramakrishnan S; Pan Y; Ma VWS; Cheuk W; So GYK; He Q; Geoffrey Lau C; Zhang L; Cho WCS; Chan KM; Wang X; Rebecca Chin Y
    Br J Cancer; 2022 Jan; 126(1):57-71. PubMed ID: 34718356
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CCAT1 promotes triple-negative breast cancer progression by suppressing miR-218/ZFX signaling.
    Han C; Li X; Fan Q; Liu G; Yin J
    Aging (Albany NY); 2019 Jul; 11(14):4858-4875. PubMed ID: 31310241
    [TBL] [Abstract][Full Text] [Related]  

  • 58. XPOT Disruption Suppresses TNBC Growth through Inhibition of Specific tRNA Nuclear Exportation and TTC19 Expression to Induce Cytokinesis Failure.
    Dai H; Yang X; Sheng X; Wang Y; Zhang S; Zhang X; Hu L; Zhang Z; Dong X; Yin W; Yao L; Lu J
    Int J Biol Sci; 2023; 19(16):5319-5336. PubMed ID: 37928256
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Up-regulated lncRNA GAS5 promotes chemosensitivity and apoptosis of triple-negative breast cancer cells.
    Li J; Li L; Yuan H; Huang XW; Xiang T; Dai S
    Cell Cycle; 2019 Aug; 18(16):1965-1975. PubMed ID: 31282278
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Microenvironmental Regulation of Long Noncoding RNA LINC01133 Promotes Cancer Stem Cell-Like Phenotypic Traits in Triple-Negative Breast Cancers.
    Tu Z; Schmöllerl J; Cuiffo BG; Karnoub AE
    Stem Cells; 2019 Oct; 37(10):1281-1292. PubMed ID: 31283068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.